Matinas biopharma reports fourth quarter and full year 2020 financial results and operational highlights

– matinas to internally focus on its lipid nanocrystal (lnc) platform to improve the intracellular delivery of critical therapeutics –

MTNB Ratings Summary

MTNB Quant Ranking